News
DefiniGEN Launches Tool for Coronavirus-Specific Intestinal Cell Research
DefiniGEN has identified iPSC-derived intestinal organoids that could be used to help structure in vitro studies of the biology of SARS-CoV2 infection across cohorts of multiple patients.
While SARS-CoV-2 primarily targets the respiratory system, studies have shown it also infects...
News
Cellect Biotechnologys ApoGraft to Empower Cellular Treatment of COVID-19 Related Pulmonary Diseases
Cellect Biotechnology Ltd., a developer of innovative technology which enables the functional selection of stem cells, announced that it has signed a development agreement with an international consortium to examine the therapeutic effects of ApoGraft treated stem cells on...
News
DTx Pharma Expands Footprint in San Diego with New Office and Lab Space
DTx Pharma, Inc. (DTx), a privately-held biotechnology company creating novel RNA-based therapeutics to treat the genetic drivers of disease, announced the expansion of its footprint into a new 14,000 square foot lab and office space, located at 10655 Sorrento...
News
Rentschler Biopharma extends its cell line development (CLD) solutions for difficult-to-express proteins
Rentschler Biopharma SE, a world-class contract development and manufacturing organization (CDMO) for biopharmaceuticals, and Horizon Discovery, a global leader in the application of gene editing and gene modulation for cell line engineering, announced the signing of a commercial license...
News
ACG receives certification for its ‘Clean Label’ capsules
ACG - a leading supplier of fully integrated solutions to the global pharmaceutical and nutraceutical industry - has received a certification of compliance from Clean Label ProjectTM for its ACGcapsTM H+. ACG Capsules has long been recognised for the quality and integrity...
News
5 Benefits of Earning A Masters Degree In Nursing
In the times that we are, care, especially in health, has triggered emphatic changes impacting patient's life like never before. There have been tremendous inroads built to counter the hurdles that at one point in time were pretty prominent....
News
bluebird bio Amends CAR-T Collaboration Agreement
bluebird bio has amended its existing co-promotion/co-development agreement with Bristol Myers Squibb (BMS) to enable the companies to focus their efforts on efficient commercialization of idecabtagene vicleucel (ide-cel; bb2121) in the U.S., the companies’ lead investigational B-cell maturation antigen...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read